フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER...
false 0001819253 0001819253 2023-06-08 2023-06-08 0001819253 us-gaap:CommonStockMember 2023-06-08 2023-06-08 0001819253 us-gaap:WarrantMember...
Biote (NASDAQ: BTMD) (the “Company,” “we” or “us”), a leading solutions provider in preventive healthcare through the delivery of personalized...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:June 07, 2023...
Filed pursuant to Rule 424(b)(3) Registration No. 333-266433 PROSPECTUS SUPPLEMENT NO. 11 (To the Prospectus...
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-265714 PROSPECTUS biote Corp. 5,217,392 Shares of...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of...
Ms. Puncochar to Drive Execution of Biote’s Strategic Sales and Marketing Initiatives biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a...
New Initiative Targets Long-term Growth Opportunity in Men’s Health Company Launches Warrant Exchange Offer and Consent Solicitation Maintains...
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone...
Mr. Denne to Accelerate Biote’s Expansion into Men’s Hormone Replacement Therapy Market Biote (NASDAQ: BTMD), a leading solutions provider in...
Achieved Full Year 2022 Record Revenue and Adjusted EBITDA for Full Year 2022 Expect 2023 Revenue of $190-200 million and Adjusted EBITDA of...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約